NURS-6630N-30-Approaches to Treatment
NURS-6630N-30-Approaches to Treatment-QTR-Term-wks-1-thru-11-
(03/01/2021-05/16/2021)-PT27
Review Test Submission: Final Exam -
Week 11
Content
Status Completed
Attempt Score 82 out of 100 points
Time Elapsed 2 hours, 8 minutes out of 2 hours and 30 minutes
Results Displayed Feedback
• Question 1
Which of the following drugs in the treatment of Alzheimer’s Disease helps normalize
glutamate by antagonizing the NMDA receptor?
• Question 2
Which features are consistent with delirium?
I. Acute onset
II. Gradual onset
III. Course of disease fluctuates
IV. Course of diseases does not fluctuate
V. Impaired attention
VI. Normal attention
Response
Feedback: “The onset of delirium is typically acute or subacute, the course often has
marked fluctuations, and level of consciousness and attention are
impaired.”
• Question 3
,NURS-6630N-30-Approaches to Treatment
Which medication is a selective alpha-adrenergic agonist that works by mimicking
norepinephrine binding in the pre-frontal cortex, which makes it particularly useful in the
treatment of ADHD?
• Question 4
The experience of pain is ALWAYS subjective
Response Feedback:
“The experience of pain is always
subjective.”
• Question 5
Select the correct description of a somatoform
disorder. Response
Feedback: - Option A That description goes with conversion disorder.
- Option B That description goes with pain disorder.
- Option D That description goes with factitious disorder with
physical symptoms.
• Question 6
Choose the correct statement regarding medications used for alcoholism
Response
Feedback: Table 15-3 has the three MOAs listed for the FDA-approved
treatments of alcoholism.
• Question 7
, NURS-6630N-30-Approaches to Treatment
Daytrana is the MPH transdermal system of methylphenidate approved for the treatment of
ADHD in children aged 6 years and older. What is the difference in terms of the metabolism
compared to the other formulations in this class?
Response
Feedback: referring to MPH transdermal system (MTS; Daytrana): “Since the MPH
is absorbed through the skin, it does not undergo first-pass metabolism by
CES-1 in the liver, resulting in higher plasma MPH levels”
• Question 8
Which of the following psychiatric conditions is present in both domains (i.e., core
psychopathology & pain-related psychological symptoms) of chronic pain that will likely
lead to an outcome of disability, pain, and poor quality of life?
Response
Feedback: Figure 17-4 and in the text on the page discussing how anxiety is
present in both, therefore, a review is needed of the exact cause of the
anxiety
• Question 9
This medication cannot be used for more than 5 days, it is a non-steroidal, anti-
inflammatory drug, and it is often substituted for morphine due to its rapid onset and high
potency. What is this medication?
Response Feedback:
under non-steroidal, anti-inflammatory drugs
• Question 10
Which medication(s) requires a test dose to determine accurate use of the drug (i.e., how
addicted the patient truly is on a certain drug) before beginning a titration schedule to
withdrawal the patient?
I. Butalbital
II. Lorazepam
NURS-6630N-30-Approaches to Treatment-QTR-Term-wks-1-thru-11-
(03/01/2021-05/16/2021)-PT27
Review Test Submission: Final Exam -
Week 11
Content
Status Completed
Attempt Score 82 out of 100 points
Time Elapsed 2 hours, 8 minutes out of 2 hours and 30 minutes
Results Displayed Feedback
• Question 1
Which of the following drugs in the treatment of Alzheimer’s Disease helps normalize
glutamate by antagonizing the NMDA receptor?
• Question 2
Which features are consistent with delirium?
I. Acute onset
II. Gradual onset
III. Course of disease fluctuates
IV. Course of diseases does not fluctuate
V. Impaired attention
VI. Normal attention
Response
Feedback: “The onset of delirium is typically acute or subacute, the course often has
marked fluctuations, and level of consciousness and attention are
impaired.”
• Question 3
,NURS-6630N-30-Approaches to Treatment
Which medication is a selective alpha-adrenergic agonist that works by mimicking
norepinephrine binding in the pre-frontal cortex, which makes it particularly useful in the
treatment of ADHD?
• Question 4
The experience of pain is ALWAYS subjective
Response Feedback:
“The experience of pain is always
subjective.”
• Question 5
Select the correct description of a somatoform
disorder. Response
Feedback: - Option A That description goes with conversion disorder.
- Option B That description goes with pain disorder.
- Option D That description goes with factitious disorder with
physical symptoms.
• Question 6
Choose the correct statement regarding medications used for alcoholism
Response
Feedback: Table 15-3 has the three MOAs listed for the FDA-approved
treatments of alcoholism.
• Question 7
, NURS-6630N-30-Approaches to Treatment
Daytrana is the MPH transdermal system of methylphenidate approved for the treatment of
ADHD in children aged 6 years and older. What is the difference in terms of the metabolism
compared to the other formulations in this class?
Response
Feedback: referring to MPH transdermal system (MTS; Daytrana): “Since the MPH
is absorbed through the skin, it does not undergo first-pass metabolism by
CES-1 in the liver, resulting in higher plasma MPH levels”
• Question 8
Which of the following psychiatric conditions is present in both domains (i.e., core
psychopathology & pain-related psychological symptoms) of chronic pain that will likely
lead to an outcome of disability, pain, and poor quality of life?
Response
Feedback: Figure 17-4 and in the text on the page discussing how anxiety is
present in both, therefore, a review is needed of the exact cause of the
anxiety
• Question 9
This medication cannot be used for more than 5 days, it is a non-steroidal, anti-
inflammatory drug, and it is often substituted for morphine due to its rapid onset and high
potency. What is this medication?
Response Feedback:
under non-steroidal, anti-inflammatory drugs
• Question 10
Which medication(s) requires a test dose to determine accurate use of the drug (i.e., how
addicted the patient truly is on a certain drug) before beginning a titration schedule to
withdrawal the patient?
I. Butalbital
II. Lorazepam
